Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by CommonCentsforDollarson Jan 05, 2021 4:15pm
241 Views
Post# 32226192

RE:RE:Frustrating price lags...

RE:RE:Frustrating price lags...Everyone complaining the day of the merger that TLRY was trading at a discount to the 0.8381. (We also complained about the 0.8381, me being one of those people. - did enough trading to be over that now) Now TLRY is trading at a premium and people not happy. I would rather they trade at a premium as every APHA shareholder should be doing the math here and realize why sell when we are trading at a discount.

TLRY has roughly half the shares outstanding which may be another factor as to why shorts will have a harder time bringing it down as well as covering current open interest. So many factors at play here. As long as the S&P / DOW doesn't have some ugly days throwing a wrench in I am perfectly fine with how it is trading. Keep lifting us up TLRY!

APHA TSX is the laggard. Will be happy to rid ourselves of the TSX and criminal house 079.

That is how I see it.


Short Sellers of APHA should also be considering the 0.8381 haircut and how that will remove roughly 15% of shares from being borrow-able to short. 

eom
momo




kingbear wrote: Tilray closes at $9.51 x 0.8381 = $.797 APHA USD which is $10.10 CAD. Aphria should be at $10.10 CAD yet we are at 9.49, what a sick joke. Never seen such a wide disparity in a merger like this. If anything Tilray should be the one that is lower in case the deal falls through. Aphria shareholders lose yet AGAIN!.
hevin wrote: Tilray at 9.24
Aprhia SHOULD be at 7.76 (but it's at 7.48)
Ahria on TSX SHOULD be at  9.72 but it's at 9.46 even lagging the lagging US Aphria price ...




<< Previous
Bullboard Posts
Next >>